SK1332000A3 - A pharmaceutical composition active in reducing production of mcp-1 protein - Google Patents
A pharmaceutical composition active in reducing production of mcp-1 protein Download PDFInfo
- Publication number
- SK1332000A3 SK1332000A3 SK133-2000A SK1332000A SK1332000A3 SK 1332000 A3 SK1332000 A3 SK 1332000A3 SK 1332000 A SK1332000 A SK 1332000A SK 1332000 A3 SK1332000 A3 SK 1332000A3
- Authority
- SK
- Slovakia
- Prior art keywords
- mcp
- protein
- pharmaceutical composition
- production
- disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT97MI001788A IT1293794B1 (it) | 1997-07-28 | 1997-07-28 | Farmaco attivo nel ridurre la produzione di proteina mcp-1 |
| PCT/EP1998/004925 WO1999004791A1 (en) | 1997-07-28 | 1998-07-22 | A pharmaceutical composition active in reducing production of mcp-1 protein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK1332000A3 true SK1332000A3 (en) | 2000-12-11 |
Family
ID=11377641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK133-2000A SK1332000A3 (en) | 1997-07-28 | 1998-07-22 | A pharmaceutical composition active in reducing production of mcp-1 protein |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6191158B1 (it) |
| EP (1) | EP0999836A1 (it) |
| JP (1) | JP2001510802A (it) |
| KR (1) | KR20010022333A (it) |
| CN (1) | CN1265592A (it) |
| AU (1) | AU9160298A (it) |
| BG (1) | BG104162A (it) |
| CA (1) | CA2298507A1 (it) |
| EA (1) | EA200000168A1 (it) |
| HU (1) | HUP0004936A3 (it) |
| IL (1) | IL134050A0 (it) |
| IT (1) | IT1293794B1 (it) |
| SK (1) | SK1332000A3 (it) |
| TR (1) | TR200000244T2 (it) |
| WO (1) | WO1999004791A1 (it) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20062254A1 (it) | 2006-11-24 | 2008-05-25 | Acraf | Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3970194A (en) * | 1975-01-08 | 1976-07-20 | Philip Morris Incorporated | Razor blade cartridge and display article |
| IT1147079B (it) * | 1980-05-30 | 1986-11-19 | Sigma Tau Ind Farmacuetiche Ri | Esteri di alcossi-acil derivati della carnitina procedimento per la loro preparatione e composizioni farmaceutiche che li contengono |
| IT1131779B (it) * | 1980-07-29 | 1986-06-25 | Acraf | Sale dell'acido (1-benzil-1h-indazol-3-il)-ossiacetico con la lisina e procedimento per la sua preparazione |
| IT1189052B (it) * | 1981-11-27 | 1988-01-28 | Acraf | Trattamento della cataratta |
| IT1197805B (it) * | 1986-08-01 | 1988-12-06 | Acraf | Metodo per il tratamento di lenti a contatto |
-
1997
- 1997-07-28 IT IT97MI001788A patent/IT1293794B1/it active IP Right Grant
-
1998
- 1998-07-22 CA CA002298507A patent/CA2298507A1/en not_active Abandoned
- 1998-07-22 IL IL13405098A patent/IL134050A0/xx unknown
- 1998-07-22 EP EP98943863A patent/EP0999836A1/en not_active Withdrawn
- 1998-07-22 HU HU0004936A patent/HUP0004936A3/hu unknown
- 1998-07-22 KR KR1020007000912A patent/KR20010022333A/ko not_active Application Discontinuation
- 1998-07-22 CN CN98807694A patent/CN1265592A/zh active Pending
- 1998-07-22 SK SK133-2000A patent/SK1332000A3/sk unknown
- 1998-07-22 AU AU91602/98A patent/AU9160298A/en not_active Abandoned
- 1998-07-22 JP JP2000503846A patent/JP2001510802A/ja active Pending
- 1998-07-22 US US09/463,665 patent/US6191158B1/en not_active Expired - Fee Related
- 1998-07-22 EA EA200000168A patent/EA200000168A1/ru unknown
- 1998-07-22 WO PCT/EP1998/004925 patent/WO1999004791A1/en not_active Application Discontinuation
- 1998-07-22 TR TR2000/00244T patent/TR200000244T2/xx unknown
-
2000
- 2000-02-17 BG BG104162A patent/BG104162A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0004936A3 (en) | 2002-01-28 |
| TR200000244T2 (tr) | 2000-09-21 |
| KR20010022333A (ko) | 2001-03-15 |
| EP0999836A1 (en) | 2000-05-17 |
| IL134050A0 (en) | 2001-04-30 |
| ITMI971788A1 (it) | 1999-01-28 |
| BG104162A (en) | 2000-12-29 |
| IT1293794B1 (it) | 1999-03-10 |
| HUP0004936A2 (hu) | 2001-11-28 |
| AU9160298A (en) | 1999-02-16 |
| EA200000168A1 (ru) | 2000-08-28 |
| CN1265592A (zh) | 2000-09-06 |
| WO1999004791A1 (en) | 1999-02-04 |
| JP2001510802A (ja) | 2001-08-07 |
| US6191158B1 (en) | 2001-02-20 |
| CA2298507A1 (en) | 1999-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2460526C2 (ru) | Профилактическое или терапевтическое средство для возрастной дегенерации желтого пятна | |
| CA2456533A1 (en) | Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs | |
| PT1201241E (pt) | Composições contendo capsaicina ou análogos de capsaicina e um anestésico | |
| US5547970A (en) | Use of leflunomide for inhibiting tumor necrosis factor alpha | |
| EP1005332B1 (en) | Pharmaceutical composition for reducing production of mcp-1 protein | |
| PL200848B1 (pl) | Zastosowanie kompleksu kwasu hialuronowego i cynku do wytwarzania środka do leczenia | |
| KR101318806B1 (ko) | 메틸페니데이트 유도체 및 그 용도 | |
| JP2003081838A (ja) | グルコサミン製剤 | |
| KR100310665B1 (ko) | 피부질환치료용약제학적조성물 | |
| SK1332000A3 (en) | A pharmaceutical composition active in reducing production of mcp-1 protein | |
| WO2000057914A1 (fr) | Agents permettant d'abaisser la tension oculaire | |
| JPS62167725A (ja) | 卒中治療剤 | |
| US6706767B2 (en) | Therapeutics for chemokine mediated diseases | |
| AU2020241731B2 (en) | Use of GABAA receptor modulators for treatment of pain | |
| EP1733723B1 (en) | Medicine capable of inhibiting activation of transcription factor klf5 | |
| JP4381495B2 (ja) | 有機ゲルマニウム化合物を有効成分とするｍｃｐ−１受容体拮抗剤、及びｍｃｐ−１が関与する炎症性疾患及び臓器障害の発症予防または治療剤 | |
| MXPA00001003A (en) | A pharmaceutical composition active in reducing production of mcp-1 protein | |
| CZ2000292A3 (cs) | Farmaceutický prostředek aktivní při snižování produkce proteinu MCP-1 | |
| JP3587851B2 (ja) | Ｔｎｆ誘発病状の治療におけるベンジダミンの使用 | |
| Shufflebarger et al. | The effect of ketorolac on microvascular thrombosis in an experimental rabbit model | |
| JPH0680009B2 (ja) | 抗高血圧組み合わせ医薬 | |
| JP3750983B2 (ja) | 骨疾患の治療剤 | |
| EP1203583A1 (en) | Remedies for arthrosis deformans | |
| MXPA01007833A (es) | Metodo para prevenir o reducir eventos cardiovasculares asociados con intervencion de la arteria coronaria. | |
| JPH05938A (ja) | 肺炎予防または治療剤 |